DEDICATED TO EXCELLENCE
We dedicate ourselves to excellence because we truly care about providing
life-changing results for patients.
MEANINGFUL WORK
We know that our individual efforts contribute to advancing science and improving human health worldwide.
FUTURE EDGE TECHNOLOGY
We research the relationships between genetics and disease then share what we learn with the global scientific community.
meet our leadership
Discovery Genomics is founded on thought leadership in healthcare and passion for advancing science. We dedicate ourselves to excellence because we truly care about providing life-changing results for patients.
CHAIRMAN
SANJAY PATIL MD MS FACC
A seasoned healthcare leader with over 30 years of experience. Dr. Patil served as CMIO & Chief Transformation Officer at Mercy Health and CEO of Cardiologist Associates.
Dr. Patil authored the earliest research in neural networks/AI in the 1990’s. He was a cardiology fellow at Harvard Medical School’s Beth Israel Deaconess Medical Center.
Dr. Patil is a board-certified cardiologist with an MD from MRMC in India, an MS in Clinical Research Design & Biostatistics from the University of Michigan, and an MA in Health Information Technology from MIT.
CHIEF EXECUTIVE OFFICER
DESMOND THIO, MD PhD DBA
Dr. Desmond Thio is the CEO of Discovery Genomics and Vice chairman of the board of directors at Excelera. He most recently served as GM and VP of IBM Watson Health Greater China and Asia Pacific. Prior to that he was in key leadership positions within several Multinational Companies including President and SVP of Philips Healthcare China, CEO DeltaHealth Hospital (Fidelity International). Pfizer/Pharmacia etc..
Dr. Thio has been sought out on global platforms including the World Economic Forum conference. He was awarded a double doctorate PhD/DBA in applied economics from University of Versailles, INSEEC, and Tsinghua University. He also holds an MBA from University of South Australia, MSc in Preventive Medicine from The Ohio State University, Doctor of Medicine (MD) from Mundial University and a BSc in Mathematics & Electrical Engineering from Dalhousie University.
CHIEF OPERATING OFFICER
AMARA SIVA, PhD
Dr. Siva is a laboratory operations executive with over 20 years of experience in molecular diagnostics and therapeutic drug discovery. In prior roles, she served as Vice President of Laboratory Operations at Millennium Health, and oversaw clinical lab operations at Genoptix / Novartis for the GxP and CLIA/CAP regulated laboratories, including establishing global clinical partner laboratories in Europe, Asia and Australia. She has held senior scientific roles at Gen-Probe, Inc. (now Hologic) and Alexion Pharmaceuticals, Inc., as well as held an Associate Faculty position in Biotechnology at MiraCosta College.
Dr. Siva earned her B.S. Biochemistry and Cell Biology from UC San Diego and Ph.D. in Biological Chemistry from UCLA. She is certified as a Clinical Genetics Molecular Biologist Scientist (CGMBS), Technologist in Molecular Biology, MB(ASCP) and ASQ Certified Six Sigma Green Belt.
CHIEF FINANCIAL OFFICER
HOLLY BRENIER
Ms. Brenier has been a leader in the healthcare and laboratory fields for over a decade. She has an extensive background performing financial, accounting, operational and administrative functions for health technology companies, managed care plans, and NGS laboratories. She began her career with Golden State Medicare Health Plan where she managed systems for cross-functional departments and oversaw finances through its transaction with the Fortune 500 company Tenet Healthcare.
Ms. Brenier is dedicated to driving positive change in healthcare service delivery and has and led all financial segments of the business from operations to regulatory audits. She holds a B.A. in Business with a Finance concentration from California State University, Fullerton.
CORPORATE LEGAL COUNSEL
BRIAN GILLAN
Brian manages business strategy, ensures legal and regulatory compliance, and manages all outside litigation. He has practiced law for 35 years, earned his B.A., cum laude, from the University of California at Irvine, and his Juris Doctor degree from the University of Illinois.
Brian was a partner at Taft, Stettinius & Hollister as well as Dinsmore & Shohl representing multibillion dollar companies. He has experience as General Counsel and Chief Operating Officer and developed a boutique practice representing C-suite executives in employment and benefits matters. For over 20 years, Brian has actively served on the Board of Directors for many charitable causes in Cincinnati.
EXECUTIVE DIRECTOR
OLIVER GUERRERO
Mr. Guerrero is a former SpaceX engineer with product as well as project management, business operations, and data analytics experience. He has led teams to successfully execute multimillion dollar ventures aligned to global strategies including the $3.1B Crew Dragon program, which became the first private-sector initiative to successfully launch humans into space. He was also one of the early commercialization team members for the Starship (BFR) program. He was previously an improvement leader focused on chemical and biological processes across several industries for Dow Chemical through its merger into Dow-Dupont.
Mr. Guerrero is a community leader with distinguished service as Planning Commissioner for the City of Pittsburg in the Bay Area, California and a professional liaison for education in Contra Costa County. He holds a B.Sc. in Chemical and Biomolecular Engineering from Cornell University and is a certified Six Sigma Green Belt Project Leader.